fenclonine has been researched along with Eosinophilia in 2 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sicuteri, F | 1 |
| Anselmi, B | 1 |
| Franchi, G | 1 |
| Fanciullacci, M | 1 |
| Del Bianco, PL | 1 |
| von Studnitz, W | 1 |
2 other studies available for fenclonine and Eosinophilia
| Article | Year |
|---|---|
[5-Hydroxytryptamine and physiopathology of pain; on a polyalgic syndrome in the course of therapy with para-chlorophenylalanine].
Topics: Catecholamines; Eosinophilia; Fenclonine; Fever; Headache; Humans; Migraine Disorders; Pain; Seroton | 1972 |
[Proceedings: Tryptophan hydroxylase inhibition as therapy for carcinoid tumors].
Topics: Carcinoid Heart Disease; Carcinoid Tumor; Constipation; Diarrhea; Eosinophilia; Fenclonine; Humans; | 1972 |